FDA Fast-Tracks Acute Myeloid Leukemia Treatment

The U.S. Food and Drug Administration has fast-tracked Celator Pharmaceuticals' experimental treatment for secondary acute myeloid leukemia (AML) in elderly patients.

Fast Track Designation from the FDA makes it more likely that, should the therapy perform well in later phase clinical trials, it will be made available to patients more quickly.

Treatment suggests it will be highly effective treating elderly patients

The treatment is currently known as CPX-351. It is a special combination of two standard chemotherapy drugs: a liposomal formulation of cytarabine and daunorubicin. Early stage clinical trials of CPX-351 suggest that it is highly effective in treating elderly patients with secondary acute myeloid leukemia (AML), a high-risk type of AML with a very poor prognosis and a disease for which the standard of care has not changed or improved in over three decades.

CPX-351 has been tested in clinical trials against standard delivery of the same two drugs (cytarabine and daunorubicin) in these patients and demonstrated higher efficacy and less toxicity. Notably, CPX-351 doubled the number of patients who achieved complete remission, and practically tripled the number of patients who survived a year following treatment.

Source: LLS

More Articles

More Articles

This article looks at the Non-Hodgkin's Lymphoma survival rate as well as the Non-Hodgkin's Lymphoma mortality rate ....

The term NK T cell lymphoma refers to one of two subtypes of lymphoma that affect the NK (Natural Killer)...

Canine lymphoma is a fairly common cancer in American dogs. The most commonly seen lymphoma in America is a type called Lymphosarcoma, although...

Prednisone is a glucocorticosteroid (a steroid) used in the treatment of many types of cancers. It functions as an anti-inflammatory medicine that...

Marginal zone lymphomas (MZL) are indolent lymphomas that affect the B-cells. The...

Large Cell Lymphoma (LCL) is typically an aggressive (fast growing) cancer of either the B cell or T cell type. They are one of the most common...

A B cell is a type of lymphocyte that produces antibodies to fight infections. These are the most prevalent lymphocytes in the bloodstream and are...

Aggressive Non-Hodgkin’s Lymphomas (NHLs) are fast growing cancers (as opposed to indolent cancers). They involve...

A lymphoma prognosis varies greatly depending on the type of lymphoma. There are more than 35 types of lymphoma, including 5 types of...

What causes lymphoma is not well known. DNA mutations may be what causes lymphoma to develop but what triggers these mutations is...

Often the one who makes the first diagnosis of Hodgkin's Lymphoma / Disease is the person affected. There are some...

Lymphedema is abnormal swelling due to the presence of excess lymphatic fluid within the tissues. This swelling occurs when the...

RICE is an acronym for an anti-cancer treatment that expresses a combination chemotherapeutic regimen. This regimen is written variously as "R+ICE...

Hodgkin's Disease—also referred to as Hodgkin's Lymphoma, these are the exact same diseases, just...

Lymphoma is a cancer affecting the white blood cells (lymphocytes) of the body's immune system. The cells begin to grow abnormally and much faster...